CIK 0001857044 · Non-accelerated filer<br>Smaller reporting company
Indaptus Therapeutics, Inc.
Sign in to watch- Ticker
- INDP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863158720
- Phone
- (646) 427-2727
- Business address
- 3 COLUMBUS CIRCLE, 15TH FLOOR, NEW YORK, NY, 10019
- Former names
- Intec Parent Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-09 | Waltzman Roger J. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2024-10-09 | Linscott Walt Addison Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2024-10-09 | Meckler Jeffrey A CEO and Director | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2024-08-08 | Meckler Jeffrey A CEO and Director | Grant or award | +84,932 | $1.83 | $155K | 160,306 |
| 2024-08-08 | Meckler Jeffrey A CEO and Director | Grant or award · Common Stock Warrants | +84,932 | $1.83 | $155K | 84,932 |
| 2024-06-06 | Karah Hila Director | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2024-06-06 | Hayes William B Director | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2024-06-06 | Martell Robert Director | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2024-06-06 | Pomerantz Roger Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2024-06-06 | MADDALUNA ANTHONY J Director | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2024-06-06 | Gilbert Mark John Director | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2024-01-22 | Linscott Walt Addison Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2024-01-22 | Meckler Jeffrey A CEO and Director | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2024-01-22 | Waltzman Roger J. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2024-01-22 | Newman Michael James CSO and Director | Grant or award · Stock Option (Right to Buy) | +43,250 | 43,250 | ||
| 2024-01-22 | Sassi Nir Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2023-08-14 | Anderson Glen R. 10% owner | Purchase | +23,934 | $2.34 | $56K | 1,190,400 |
| 2023-08-11 | Anderson Glen R. 10% owner | Purchase | +35,064 | $2.12 | $74K | 1,166,466 |
| 2023-08-10 | Anderson Glen R. 10% owner | Purchase | +44,354 | $1.94 | $86K | 1,131,402 |
| 2023-08-07 | Waltzman Roger J. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 |
Page 4 of 7 · 127 trades